Search
-
Nestlé Health Science & Ipsos Collaboration: Groundbreaking Tool for parental Cow’s Milk Allergy concerns
From cry to comfort: Ipsos Switzerland's in-depth analysis contributes to refining a pioneering awareness tool for parents concerned about infant cow's milk allergy.
-
European Observatory of Rare Diseases reveals that Europeans find conditions for patients with rare diseases are unacceptable
ASAP FOR CHILDREN has published the results of its third European Rare Disease Observatory conducted by Ipsos.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
Inspiring Better Healthcare
Commercial success in the healthcare sector means putting the patient at the heart of every decision...
-
Data Dive: Coronavirus crisis leaves scars, lessons in its wake
Four years after the WHO first declared a global health emergency we look at how views on everything from inflation to mental health have changed since 2020.
-
The doctor-patient relationship in the generative AI era
Five reasons why the time to act for pharma is now.
-
Ipsos launches Non-Interventional Studies (NIS) Centre of Expertise
The new NIS Centre of Expertise, part of Ipsos’ global healthcare business, consolidates Ipsos’ extensive capabilities in real world evidence, an area of increasing priority for healthcare companies.
-
Annual results - Strong performance in an uncertain environment
Ipsos achieved a strong performance in 2022, with a record level of profitability, demonstrating the strength and relevance of its operating model.